Healthy donor T cell responses to common cold coronaviruses and SARS-CoV-2

Science

(2023) · doi:10.1126/science · Cited by 6,063 · see citing works

Signals from chloroplasts converge to regulate nuclear gene expression.

Koussevitzky, S., Nott, A., Mockler, T. C., Hong, F., Sachetto‐Martins, G., Surpin, M. A., Lim, J. C.-S., Mittler, R., & Chory, J. (2007) · PubMed · doi:10.1126/science.1140516 · Cited by 5,076 · see citing works

Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals

Grifoni, A., Weiskopf, D., Ramirez, S. I., Mateus, J., Dan, J. M., Moderbacher, C. R., Rawlings, S. A., Sutherland, A., Premkumar, L., Jadi, R. S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.015 · Cited by 3,595 · see citing works

The Immune Epitope Database (IEDB): 2018 update

Vita, R., Mahajan, S., Overton, J. A., Dhanda, S. K., Martini, S. R., Cantrell, J. R., Wheeler, D. K., Sette, A., & Peters, B. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky1006 · Cited by 2,194 · see citing works

SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls

Le Bert, N., Tan, A. T., Kunasegaran, K., Tham, C. Y. L., Hafezi, M., Chia, A., Chng, M. H. Y., Lin, M., Tan, N., Linster, M., et al. (2020) · Nature · doi:10.1038/s41586-020-2550-z · Cited by 1,887 · see citing works

Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19

Sekine, T., Perez-Potti, A., Rivera-Ballesteros, O., Strålin, K., Gorin, J.-B., Olsson, A., Llewellyn-Lacey, S., Kamal, H., Bogdanovic, G., Muschiol, S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.08.017 · Cited by 1,788 · see citing works

Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial

Zhu, F.-C., Li, Y.-H., Guan, X.-H., Hou, L.-H., Wang, W.-J., Li, J.-X., Wu, S.-P., Wang, B.-S., Wang, Z., Wang, L., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31208-3 · Cited by 1,382 · see citing works

SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19

Braun, J., Loyal, L., Frentsch, M., Wendisch, D., Georg, P., Kurth, F., Hippenstiel, S., Dingeldey, M., Kruse, B., Fauchere, F., et al. (2020) · Nature · doi:10.1038/s41586-020-2598-9 · Cited by 1,310 · see citing works

Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19

Peng, Y., Mentzer, A. J., Liu, G., Yao, X., Yin, Z., Dong, D., Dejnirattisai, W., Rostron, T., Supasa, P., Liu, C., et al. (2020) · Nature Immunology · doi:10.1038/s41590-020-0782-6 · Cited by 1,179 · see citing works

Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans

Mateus, J., Grifoni, A., Tarke, A., Sidney, J., Ramirez, S. I., Dan, J. M., Burger, Z. C., Rawlings, S. A., Smith, D. M., Phillips, E., et al. (2020) · Science · doi:10.1126/science.abd3871 · Cited by 1,120 · see citing works

Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals

Ni, L., Ye, F., Cheng, M., Yu, F., Deng, Y., Zhao, H. J., Peng, W., Ge, J., Gou, M., Li, X., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.04.023 · Cited by 1,069 · see citing works

Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome

Weiskopf, D., Schmitz, K. S., Raadsen, M. P., Grifoni, A., Okba, N. M. A., Endeman, H., van den Akker, J. P. C., Molenkamp, R., Koopmans, M. P. G., van Gorp, E. C. M., et al. (2020) · Science Immunology · doi:10.1126/sciimmunol.abd2071 · Cited by 907 · see citing works

Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19

Rodda, L. B., Netland, J., Shehata, L., Pruner, K. B., Morawski, P. A., Thouvenel, C. D., Takehara, K. K., Eggenberger, J., Hemann, E. A., Waterman, H. R., et al. (2021) · Cell · doi:10.1016/j.cell.2020.11.029 · Cited by 647 · see citing works

The time course of the immune response to experimental coronavirus infection of man

Callow, K. A., Parry, H. F., Sergeant, M., & Tyrrell, D. A. J. (1990) · Epidemiology and Infection · doi:10.1017/s0950268800048019 · Cited by 598 · see citing works

Imbalance of Regulatory and Cytotoxic SARS-CoV-2-Reactive CD4+ T Cells in COVID-19

Meckiff, B. J., Ramírez-Suástegui, C., Fajardo, V., Chee, S., Kusnadi, A., Simon, H. A., Eschweiler, S., Grifoni, A., Pelosi, E., Weiskopf, D., et al. (2020) · Cell · doi:10.1016/j.cell.2020.10.001 · Cited by 564 · see citing works

T Cell Responses to Whole SARS Coronavirus in Humans

Li, C. K., Wu, H., Yan, H., Ma, S., Wang, L., Zhang, M., Tang, X., Temperton, N. J., Weiss, R. A., Brenchley, J. M., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.8.5490 · Cited by 488 · see citing works

Functional SARS-CoV-2-specific immune memory persists after mild COVID-19Preprint

Rodda, L., Netland, J., Shehata, L., Pruner, K. B., Morwaski, P. A., Thouvenel, C., Takehara, K., Eggenberger, J., Hemann, E. A., Waterman, H., et al. (2020) · medRxiv · doi:10.1101/2020.08.11.20171843 · Cited by 407 · see citing works

Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19Preprint

Sekine, T., Perez‐Potti, A., Rivera‐Ballesteros, O., Strålin, K., Gorin, J., Olsson, A., Llewellyn‐Lacey, S., Kamal, H., Bogdanović, G., Muschiol, S., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.29.174888 · Cited by 272 · see citing works

Intrafamilial Exposure to SARS-CoV-2 Associated with Cellular Immune Response without Seroconversion, France

Gallais, F., Velay, A., Wendling, M.-J., Nazon, C., Partisani, M., Sibilia, J., Candon, S., & Fafi‐Kremer, S. (2020) · Emerging infectious diseases · doi:10.3201/eid2701.203611 · Cited by 260 · see citing works

Magnitude and Dynamics of the T-Cell Response to SARS-CoV-2 Infection at Both Individual and Population LevelsPreprint

Snyder, T. M., Gittelman, R. M., Klinger, M., et al. (2020) · medRxiv · doi:10.1101/2020.07.31.20165647 · Cited by 234 · see citing works

Magnitude and dynamics of the T-cell response to SARS-CoV-2 infection at both individual and population levels

Snyder, T. M., Gittelman, R. M., Klinger, M., May, D., Osborne, E. J., Taniguchi, R. T., Zahid, H. J., Kaplan, I. M., Dines, J. N., Noakes, M. T., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1488860 · Cited by 206 · see citing works

SARS–CoV-2–specific T cell responses and correlations with COVID-19 patient predisposition

Sattler, A., Angermair, S., Stockmann, H., Heim, K. M., Khadzhynov, D., Treskatsch, S., Halleck, F., Kreis, M. E., & Kotsch, K. (2020) · Journal of Clinical Investigation · doi:10.1172/jci140965 · Cited by 196 · see citing works

SARS-CoV-2-Specific T Cells Exhibit Phenotypic Features of Helper Function, Lack of Terminal Differentiation, and High Proliferation Potential

Neidleman, J., Luo, X., Frouard, J., Xie, G., Gill, G., Stein, E. S., McGregor, M., Ma, T., George, A. F., Kosters, A., et al. (2020) · Cell Reports Medicine · doi:10.1016/j.xcrm.2020.100081 · Cited by 188 · see citing works

Direct Observation of Repeated Infections With Endemic Coronaviruses

Galanti, M., & Shaman, J. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa392 · Cited by 149 · see citing works

Antibody response against SARS-CoV-2 spike protein and nucleoprotein evaluated by four automated immunoassays and three ELISAs

Elslande, J. V., Decru, B., Jonckheere, S., Wijngaerden, E. V., Houben, E., Vandecandelaere, P., Indevuyst, C., Depypere, M., Desmet, S., André, E., et al. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.07.038 · Cited by 142 · see citing works

Human Coronavirus NL63 Molecular Epidemiology and Evolutionary Patterns in Rural Coastal Kenya

Kiyuka, P. K., Agoti, C. N., Munywoki, P. K., Njeru, R., Bett, A., Otieno, J. R., Otieno, G. P., Kamau, E., Clark, T. G., van der Hoek, L., et al. (2018) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiy098 · Cited by 122 · see citing works

Intrafamilial Exposure to SARS-CoV-2 Induces Cellular Immune Response without SeroconversionPreprint

Gallais, F., Velay, A., Wendling, M.-J., et al. (2020) · medRxiv · doi:10.1101/2020.06.21.20132449 · Cited by 111 · see citing works

Development of a Nucleocapsid-Based Human Coronavirus Immunoassay and Estimates of Individuals Exposed to Coronavirus in a U.S. Metropolitan Population

Severance, E. G., Bossis, I., Dickerson, F., Stallings, C. R., Origoni, A. E., Sullens, A., Yolken, R. H., & Viscidi, R. P. (2008) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00124-08 · Cited by 101 · see citing works

Broad and strong memory CD4 + and CD8 + T cells induced by SARS-CoV-2 in UK convalescent COVID-19 patientsPreprint

Peng, Y., Mentzer, A. J., Liu, G., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.05.134551 · Cited by 96 · see citing works

What’s New With the Old Coronaviruses?

Ogimi, C., Kim, Y. J., Martin, E. T., Huh, H. J., Chiu, C., & Englund, J. A. (2020) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/piaa037 · Cited by 77 · see citing works

Interferon Alpha Enhances NK Cell Function and the Suppressive Capacity of HIV-Specific CD8+T Cells

Kwaa, A. K., Talana, C. A., & Blankson, J. N. (2018) · Journal of Virology · doi:10.1128/jvi.01541-18 · Cited by 56 · see citing works

Evaluation of Serological SARS-CoV-2 Lateral Flow Assays for Rapid Point-of-Care Testing

Conklin, S. E., Martin, K., Manabe, Y. C., Schmidt, H. A., Miller, J., Keruly, M., Klock, E., Kirby, C. S., Baker, O. R., Fernández, R. E., et al. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.02020-20 · Cited by 56 · see citing works

Direct observation of repeated infections with endemic coronavirusesPreprint

Galanti, M., & Shaman, J. L. (2020) · medRxiv · doi:10.1101/2020.04.27.20082032 · Cited by 55 · see citing works

SARS‐CoV‐2‐reactive interferon‐γ‐producing CD8+ T cells in patients hospitalized with coronavirus disease 2019

Giménez, E., Albert, E., Torres, I., Remigia, M. J., Alcaráz, M. J., Galindo, M. J., Blasco, M. L., Solano, C., Forner, M. J., Redón, J., et al. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26213 · Cited by 47 · see citing works

Single-cell transcriptomic analysis of SARS-CoV-2 reactive CD4 + T cellsPreprint

Meckiff, B. J., Ramírez-Suástegui, C., Fajardo, V., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.12.148916 · Cited by 45 · see citing works

Long-term remission despite clonal expansion of replication-competent HIV-1 isolates

Veenhuis, R. T., Kwaa, A. K., Garliss, C. C., Latanich, R., Salgado, M., Pohlmeyer, C. W., Nobles, C. L., Gregg, J., Scully, E. P., Bailey, J. R., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.122795 · Cited by 40 · see citing works

COVID-19 patients display distinct SARS-CoV-2 specific T-cell responses according to disease severity

Kroemer, M., Spehner, L., Vettoretti, L., Bouard, A., Eberst, G., Pili‐Floury, S., Capellier, G., Lepiller, Q., Orillard, É., Mansi, L., et al. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.08.036 · Cited by 35 · see citing works

Evaluation of Serological SARS-CoV-2 Lateral Flow Assays for Rapid Point of Care TestingPreprint

Conklin, S. E., Martin, K., Manabe, Y. C., et al. (2020) · medRxiv · doi:10.1101/2020.07.31.20166041 · Cited by 18 · see citing works

Cross-reactive microbial peptides can modulate HIV-specific CD8+ T cell responses

Pohlmeyer, C. W., Laskey, S. B., Beck, S. E., Xu, D. C., Capoferri, A. A., Garliss, C. C., May, M. E., Livingston, A. G., Lichmira, W., Moore, R. D., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0192098 · Cited by 9 · see citing works

Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection

Cromer, D., Juno, J. A., Khoury, D., Reynaldi, A., Wheatley, A. K., Kent, S. J., & Davenport, M. P. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-021-00550-x · Cited by 265 · see citing works

Humoral Responses and Serological Assays in SARS-CoV-2 Infections

Galipeau, Y., Greig, M., Liu, C., Driedger, M., & Langlois, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.610688 · Cited by 239 · see citing works

SARS-CoV-2-specific T cell memory is sustained in COVID-19 convalescent patients for 10 months with successful development of stem cell-like memory T cells

Jung, J. H., Rha, M., Sa, M., Choi, H. K., Jeon, J. H., Seok, H., Park, D. W., Park, S., Jeong, H. W., Choi, W. S., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24377-1 · Cited by 228 · see citing works

SARS-CoV-2 mRNA vaccines induce broad CD4+ T cell responses that recognize SARS-CoV-2 variants and HCoV-NL63

Woldemeskel, B. A., Garliss, C. C., & Blankson, J. N. (2021) · Journal of Clinical Investigation · doi:10.1172/jci149335 · Cited by 175 · see citing works

Molecular Basis of the Therapeutical Potential of Clove (Syzygium aromaticum L.) and Clues to Its Anti-COVID-19 Utility

Vicidomini, C., Roviello, V., & Roviello, G. N. (2021) · Molecules · doi:10.3390/molecules26071880 · Cited by 141 · see citing works

The Case for S2: The Potential Benefits of the S2 Subunit of the SARS-CoV-2 Spike Protein as an Immunogen in Fighting the COVID-19 Pandemic

Shah, P., Canziani, G., Carter, E. P., & CHAIKEN, I. M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.637651 · Cited by 109 · see citing works

Functional characterization of CD4+ T cell receptors crossreactive for SARS-CoV-2 and endemic coronaviruses

Dykema, A. G., Zhang, B., Woldemeskel, B. A., Garliss, C. C., Cheung, L. S., Choudhury, D. M., Zhang, J., Aparicio, L., Bom, S., Rashid, R., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci146922 · Cited by 82 · see citing works

Nucleoside Analogs and Nucleoside Precursors as Drugs in the Fight against SARS-CoV-2 and Other Coronaviruses

Borbone, N., Piccialli, G., Roviello, G. N., & Oliviero, G. (2021) · Molecules · doi:10.3390/molecules26040986 · Cited by 78 · see citing works

Differential T-Cell Reactivity to Endemic Coronaviruses and SARS-CoV-2 in Community and Health Care Workers

Antunes, R. D. S., Pallikkuth, S., Williams, E., Yu, E. D., Mateus, J., Quiambao, L. G., Wang, E. W., Rawlings, S. A., Stadlbauer, D., Jiang, K., et al. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab176 · Cited by 70 · see citing works

The battle between host and SARS-CoV-2: Innate immunity and viral evasion strategies

Zhang, S., Wang, L., & Cheng, G. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.02.014 · Cited by 75 · see citing works

SARS-CoV-2 responsive T cell numbers and anti-Spike IgG levels are both associated with protection from COVID-19: A prospective cohort study in keyworkers

Wyllie, D., Jones, H. E., Mulchandani, R., Trickey, A., Taylor-Phillips, S., Brooks, T., Charlett, A., Ades, A., EDSAB-HOME investigators, Moore, P., et al. (2020) · doi:10.1101/2020.11.02.20222778 · Cited by 96 · see citing works

Anti-Coronavirus Vaccines: Past Investigations on SARS-CoV-1 and MERS-CoV, the Approved Vaccines from BioNTech/Pfizer, Moderna, Oxford/AstraZeneca and others under Development Against SARSCoV- 2 Infection

Costanzo, M., Giglio, M. A. R. D., & Roviello, G. N. (2021) · Current Medicinal Chemistry · doi:10.2174/0929867328666210521164809 · Cited by 62 · see citing works

Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics

Nagler, A., Kalaora, S., Barbolin, C., Gangaev, A., Ketelaars, S. L. C., Alon, M., Pai, J. A., Benedek, G., Yahalom-Ronen, Y., Noam Erez, A., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109305 · Cited by 46 · see citing works

Identification of conserved SARS-CoV-2 spike epitopes that expand public cTfh clonotypes in mild COVID-19 patients

Lu, X., Hosono, Y., Nagae, M., Ishizuka, S., Ishikawa, E., Motooka, D., Ozaki, Y., Sax, N., Maeda, Y., Kato, Y., et al. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20211327 · Cited by 44 · see citing works

Durability of SARS-CoV-2–Specific T-Cell Responses at 12 Months Postinfection

Lu, Z., Laing, E. D., DaMata, J. P., Pohida, K., Tso, M. S., Samuels, E. C., Epsi, N. J., Dorjbal, B., Lake, C. M., Richard, S. A., et al. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab543 · Cited by 41 · see citing works

The New Kid on the Block: HLA-C, a Key Regulator of Natural Killer Cells in Viral Immunity

Vollmers, S., Lobermeyer, A., & Körner, C. (2021) · Cells · doi:10.3390/cells10113108 · Cited by 45 · see citing works

Mouse models susceptible to HCoV-229E and HCoV-NL63 and cross protection from challenge with SARS-CoV-2

Liu, D., Chen, C., Chen, D., Zhu, A., Li, F., Zhuang, Z., Mok, C. K. P., Dai, J., Li, X., Jin, Y., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2202820120 · Cited by 41 · see citing works

Cross-reactive and mono-reactive SARS-CoV-2 CD4+ T cells in prepandemic and COVID-19 convalescent individuals

Johansson, A. M., Malhotra, U., Kim, Y. G., Gomez, R., Krist, M. P., Wald, A., Koelle, D. M., & Kwok, W. W. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1010203 · Cited by 35 · see citing works

Immunity after COVID-19 Recovery and Vaccination: Similarities and Differences

Kamińska, D., Dęborska−Materkowska, D., Kościelska−Kasprzak, K., Mazanowska, O., Remiorz, A., Poznański, P., Durlik, M., & Krajewska, M. (2022) · Vaccines · doi:10.3390/vaccines10071068 · Cited by 32 · see citing works

CD4+ T cells from COVID-19 mRNA vaccine recipients recognize a conserved epitope present in diverse coronaviruses

Woldemeskel, B. A., Dykema, A. G., Garliss, C. C., Cherfils, S., Smith, K. N., & Blankson, J. N. (2022) · Journal of Clinical Investigation · doi:10.1172/jci156083 · Cited by 28 · see citing works

Cross-Reactive Immune Responses toward the Common Cold Human Coronaviruses and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Mini-Review and a Murine Study

Sealy, R. E., & Hurwitz, J. L. (2021) · Microorganisms · doi:10.3390/microorganisms9081643 · Cited by 29 · see citing works

A quest for universal anti-SARS-CoV-2 T cell assay: systematic review, meta-analysis, and experimental validation

Binayke, A., Zaheer, A., Vishwakarma, S., Singh, S., Sharma, P., Chandwaskar, R., Gosain, M., Raghavan, S., Murugesan, D. R., Kshetrapal, P., et al. (2024) · npj Vaccines · doi:10.1038/s41541-023-00794-9 · Cited by 28 · see citing works

Impaired Priming of SARS-CoV-2-Specific Naive CD8+ T Cells in Older Subjects

Gallerani, E., Proietto, D., Dallan, B., Campagnaro, M., Pacifico, S., Albanese, V., Marzola, E., Marconi, P., Caputo, A., Appay, V., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.693054 · Cited by 26 · see citing works

Potent high-avidity neutralizing antibodies and T cell responses after COVID-19 vaccination in individuals with B cell lymphoma and multiple myeloma

Keppler‐Hafkemeyer, A., Greil, C., Wratil, P. R., Shoumariyeh, K., Stern, M., Hafkemeyer, A., Ashok, D., Hollaus, A., Lupoli, G., Priller, A., et al. (2022) · Nature Cancer · doi:10.1038/s43018-022-00502-x · Cited by 27 · see citing works

Pneumococcal and Influenza Vaccination Rates and Pneumococcal Invasive Disease Rates Set Geographical and Ethnic Population Susceptibility to Serious COVID-19 Cases and Deaths

Root-Bernstein, R. S. (2021) · Vaccines · doi:10.3390/vaccines9050474 · Cited by 23 · see citing works

SARS-CoV-2–specific immune responses in boosted vaccine recipients with breakthrough infections during the Omicron variant surge

Woldemeskel, B. A., Garliss, C. C., Aytenfisu, T. Y., Johnston, T. S., Beck, E. J., Dykema, A. G., Frumento, N., Wright, D. A., Yang, A. H., Damanakis, A. I., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.159474 · Cited by 21 · see citing works

SARS-CoV-2 vaccination diversifies the CD4+ spike-reactive T cell repertoire in patients with prior SARS-CoV-2 infection

Dykema, A. G., Zhang, B., Woldemeskel, B. A., Garliss, C. C., Rashid, R., Westlake, T., Zhang, L., Zhang, J., Cheung, L. S., Caushi, J. X., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104048 · Cited by 22 · see citing works

High‐resolution analysis of individual spike peptide‐specific CD4 + T‐cell responses in vaccine recipients and COVID‐19 patients

Karsten, H., Cords, L., Westphal, T., Knapp, M., Brehm, T., Hermanussen, L., Omansen, T., Schmiedel, S., Woost, R., Ditt, V., et al. (2022) · Clinical & Translational Immunology · doi:10.1002/cti2.1410 · Cited by 20 · see citing works

Adaptive immunity to human coronaviruses is widespread but low in magnitude

Tan, H., Lee, W. S., Wragg, K. M., Nelson, C., Esterbauer, R., Kelly, H. G., Amarasena, T. H., Jones, R. M., Starkey, G., Wang, B. Z., et al. (2021) · Clinical & Translational Immunology · doi:10.1002/cti2.1264 · Cited by 18 · see citing works

Novel T cell interferon gamma release assay (IGRA) using spike recombinant protein for COVID19 vaccine response and Nucleocapsid for SARS-Cov2 response

Renaudineau, Y., Abravanel, F., Izopet, J., Bost, C., Treiner, E., Congy‐Jolivet, N., & Blancher, A. (2022) · Clinical Immunology · doi:10.1016/j.clim.2022.108979 · Cited by 18 · see citing works

Immunopeptidome profiling of human coronavirus OC43-infected cells identifies CD4 T-cell epitopes specific to seasonal coronaviruses or cross-reactive with SARS-CoV-2

Becerra‐Artiles, A., Nanaware, P. P., Muneeruddin, K., Weaver, G. C., Shaffer, S. A., Calvo‐Calle, J. M., & Stern, L. J. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1011032 · Cited by 16 · see citing works

Circulating CD4 T Cells Elicited by Endemic Coronaviruses Display Vast Disparities in Abundance and Functional Potential Linked to Antigen Specificity and Age

Richards, K. A., Glover, M. A., Crawford, J. C., Thomas, P. G., White, C. L., & Sant, A. J. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab076 · Cited by 16 · see citing works

Assessment of T-cell immunity to SARS-CoV-2 in COVID-19 convalescents and vaccinated subjects, using TigraTest® SARS-CoV-2 ELISPOT kit

Poteryaev, D. A., Abbasova, S. G., Ignatyeva, P. E., Strizhakova, O. M., Владимировна, К. С., & Авгатович, Х. Р. (2021) · Biological Products Prevention Diagnosis Treatment · doi:10.30895/2221-996x-2021-21-3-178-192 · Cited by 15 · see citing works

SARS-CoV-2 spike antigen-specific B cell and antibody responses in pre-vaccination period COVID-19 convalescent males and females with or without post-covid condition

Limoges, M.-A., Quenum, A., Chowdhury, M. M. H., Rexhepi, F., Namvarpour, M., Akbari, S. A., Rioux‐Perreault, C., Nandi, M., Lucier, J., Lemaire‐Paquette, S., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1223936 · Cited by 11 · see citing works

Long-Term, CD4+ Memory T Cell Response to SARS-CoV-2

Wirsching, S., Harder, L. H., Heymanns, M., Gröndahl, B., Hilbert, K., Kowalzik, F., Meyer, C. U., & Gehring, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.800070 · Cited by 11 · see citing works

Development of an Effective Immune Response in Adults With Down Syndrome After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccination

Esparcia-Pinedo, L., Yarci-Carrión, A., Mateo-Jiménez, G., Ropero, N., Gómez, L., Lancho, A., Almendro-Vázquez, P., Martín‐Gayo, E., Paz‐Artal, E., Sánchez‐Madrid, F., et al. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac590 · Cited by 11 · see citing works

Differentiation of Individuals Previously Infected with and Vaccinated for SARS-CoV-2 in an Inner-City Emergency Department

Beck, E. J., Hsieh, Y., Fernández, R. E., Dashler, G., Egbert, E. R., Truelove, S. A., Garliss, C. C., Wang, R., Bloch, E. M., Shrestha, R., et al. (2022) · Journal of Clinical Microbiology · doi:10.1128/jcm.02390-21 · Cited by 12 · see citing works

Adaptive immune responses in vaccinated patients with symptomatic SARS-CoV-2 Alpha infection

Park, H.-S., Shapiro, J. R., Sitaras, I., Woldemeskel, B. A., Garliss, C. C., Dziedzic, A., Sachithanandham, J., Jedlicka, A., Caputo, C. A., Rousseau, K. E., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.155944 · Cited by 12 · see citing works

Human seasonal coronavirus neutralization and COVID‐19 severity

Wells, D. A., Cantoni, D. M., Neto, M. M., Genova, C. D., Sampson, A., Ferrari, M., Carnell, G., Nadesalingam, A., Smith, P., Chan, A., et al. (2022) · Journal of Medical Virology · doi:10.1002/jmv.27937 · Cited by 10 · see citing works

CD4+ T Cell Immune Specificity Changes After Vaccination in Healthy And COVID-19 Convalescent Subjects

Esparcia-Pinedo, L., Martínez‐Fleta, P., Ropero, N., Vera-Tomé, P., Reyburn, H. T., Casasnovas, J. M., Rodrı́guez-Frade, J. M., Valés‐Gómez, M., Vilches, C., Martín‐Gayo, E., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.755891 · Cited by 11 · see citing works

Bivalent mRNA COVID vaccines elicit predominantly cross-reactive CD4+ T cell clonotypes

Sop, J., Traut, C. C., Dykema, A. G., Hunt, J. H., Beckey, T. P., Basseth, C. R., Antar, A. A. R., Laeyendecker, O. B., Smith, K. N., & Blankson, J. N. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101442 · Cited by 10 · see citing works

The immunobiology of SARS-CoV-2 infection and vaccine responses: potential influences of cross-reactive memory responses and aging on efficacy and off-target effects

Collins, C. P., Longo, D. L., & Murphy, W. J. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1345499 · Cited by 9 · see citing works

Preservation of antigen-specific responses in cryopreserved CD4+ and CD8+ T cells expanded with IL-2 and IL-7

Clarkson, B. D. S., Johnson, R. K., Bingel, C., Lothaller, C., & Howe, C. L. (2022) · Journal of Translational Autoimmunity · doi:10.1016/j.jtauto.2022.100173 · Cited by 9 · see citing works

Most Japanese individuals are genetically predisposed to recognize an immunogenic protein fragment shared between COVID-19 and common cold coronaviruses

Dijkstra, J. M., Frenette, A. P., & Dixon, B. (2021) · F1000Research · doi:10.12688/f1000research.51479.1 · Cited by 9 · see citing works

Seasonal Betacoronavirus Antibodies’ Expansion Post-BNT161b2 Vaccination Associates with Reduced SARS-CoV-2 VoC Neutralization

Dispinseri, S., Marzinotto, I., Brigatti, C., Pirillo, M. F., Tolazzi, M., Bazzigaluppi, E., Canitano, A., Borghi, M., Gallinaro, A., Caccia, R., et al. (2022) · Journal of Clinical Immunology · doi:10.1007/s10875-021-01190-5 · Cited by 9 · see citing works

Humoral and Cellular Immune Response to a Third Dose of SARS-CoV-2 Vaccine in Kidney Transplant Recipients Taking Belatacept

Mitchell, J., Kim, J., Alejo, J. L., Chiang, T. P.-Y., Karaba, A. H., Blankson, J. N., Aytenfisu, T. Y., Chang, A., Abedon, A. T., Avery, R. K., et al. (2022) · Transplantation · doi:10.1097/tp.0000000000004100 · Cited by 9 · see citing works

Germline homozygosity and allelic imbalance of HLA-I are common in esophagogastric adenocarcinoma and impair the repertoire of immunogenic peptides

Garcia-Marquez, M. A., Thelen, M., Bauer, E., Maas, L., Wennhold, K., Lehmann, J. M., Keller, D. T., Nikolić, M., George, J., Zander, T., et al. (2024) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2023-007268 · Cited by 8 · see citing works

Distinct T cell polyfunctional profile in SARS-CoV-2 seronegative children associated with endemic human coronavirus cross-reactivity

Benede, N., Tincho, M. B., Walters, A., Subbiah, V., Ngomti, A., Baguma, R., Butters, C., Hähnle, L., Mennen, M., Skelem, S., et al. (2023) · iScience · doi:10.1016/j.isci.2023.108728 · Cited by 10 · see citing works

Antibodies to Seasonal Coronaviruses Rarely Cross-React With SARS-CoV-2

Zar, H. J., Nicol, M. P., MacGinty, R., Workman, L., Petersen, W., Johnson, M., & Goldblatt, D. (2021) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000003325 · Cited by 8 · see citing works

Pattern Recognition Receptors (PRRs) Expression and Activation in COVID-19 and Long COVID: From SARS-CoV-2 Escape Mechanisms to Emerging PRR-Targeted Immunotherapies

Maddaloni, L., Bugani, G., Fracella, M., Bitossi, C., D’Auria, A., Aloisi, F., Azri, A., Santinelli, L., M’hadheb-Gharbi, M. B., Pierangeli, A., et al. (2025) · Microorganisms · doi:10.3390/microorganisms13092176 · Cited by 8 · see citing works

Prevalence of COVID-19-associated symptoms during acute infection in relation to SARS-CoV-2-directed humoral and cellular immune responses in a mild-diseased convalescent cohort

Tegeler, C. M., Bilich, T., Maringer, Y., Salih, H. R., Walz, J. S., Nelde, A., & Heitmann, J. S. (2022) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2022.04.019 · Cited by 7 · see citing works

Impaired T-cell and antibody immunity after COVID-19 infection in chronically immunosuppressed transplant recipientsPreprint

Ashokkumar, C., Rohan, V., Kroemer, A., Rao, S., Mazariegos, G. V., Higgs, B. W., Nadig, S. N., Almeda, J. L., Dhani, H., Khan, K., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.05.03.442371 · Cited by 7 · see citing works

Interferon-lambda: New functions on intestinal symptoms in COVID-19

Pan, Y., Wang, L.-C., Yang, F., & Yu, M. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i13.1942 · Cited by 6 · see citing works

Altered pre-existing SARS-CoV-2-specific T cell responses in elderly individuals

Taira, N., Toguchi, S., Miyagi, M., Mori, T., Tomori, H., Oshiro, K., Tamai, O., Kina, M., Miyagi, M., Tamaki, K., et al. (2021) · Clinical Immunology Communications · doi:10.1016/j.clicom.2021.12.001 · Cited by 6 · see citing works

First- and Second-Generation Nucleoside Triphosphate Prodrugs: TriPPPro-Compounds for Antiviral Chemotherapy

Jia, X. D., Zhao, C., & Meier, C. (2023) · Springer eBooks · doi:10.1007/978-981-19-9776-1_72 · Cited by 6 · see citing works

Development of an in-house SARS-CoV-2 interferon-gamma ELISpot and plate reader-free spot detection method

Mak, W. A., Koeleman, J. G. M., & Ong, D. S. Y. (2021) · Journal of Virological Methods · doi:10.1016/j.jviromet.2021.114398 · Cited by 6 · see citing works

Assessing T-Cell Immunity in Kidney Transplant Recipients with Absent Antibody Production after a 3rd Dose of the mRNA-1273 Vaccine

Infantino, M. G., Tsalouchos, A., Russo, E., Laudicina, S., Grossi, V., Lari, B., Benucci, M., Stacchini, L., Amedei, A., Casprini, P., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012333 · Cited by 5 · see citing works

HLA-I and HLA-II Peptidomes of SARS-CoV-2: A Review

El‐Baky, N. A., Amara, A. A. A. F., & Redwan, E. M. M. M. (2023) · Vaccines · doi:10.3390/vaccines11030548 · Cited by 5 · see citing works

Humoral and cell-mediated immune responses to BNT162b2 vaccine against SARS-CoV-2 in people with cystic fibrosis

Alicandro, G., Orena, B. S., Rosazza, C., Cariani, L., Russo, M. C., Zatelli, M., Badolato, R., Gramegna, A., Blasi, F., & Daccò, V. (2023) · Vaccine · doi:10.1016/j.vaccine.2023.05.041 · Cited by 6 · see citing works

Tetanus-diphtheria vaccine can prime SARS-CoV-2 cross-reactive T cells

Fernandez, S. A., Pelaez-Prestel, H. F., Fiyouzi, T., Gomez‐Perosanz, M., Reiné, J., & Reche, P. A. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1425374 · Cited by 5 · see citing works

The COVID-19 pandemic in sub-Saharan Africa: The significance of presumed immune sufficiency

Idowu, A. O., Omosun, Y., Igietseme, J. U., & Azenabor, A. A. (2023) · African Journal of Laboratory Medicine · doi:10.4102/ajlm.v12i1.1964 · Cited by 3 · see citing works

Potential use of endemic human coronaviruses to stimulate immunity against pathogenic SARS-CoV-2 and its variants

Shamabadi, N. S., Bagasra, A. B., Pawar, S., & Bagasra, O. (2023) · Libyan Journal of Medicine · doi:10.1080/19932820.2023.2209949 · Cited by 3 · see citing works

An Immune Response to Heterologous ChAdOx1/BNT162b2 Vaccination against COVID-19: Evaluation of the anti-RBD Specific IgG Antibodies Titers and Interferon Gamma Release Assay (IGRA) Test Results

Zalewska−Ziob, M., Fus, W., Konka, A., Wystyrk, K., Bochenek, A., Botor, H., Fronczek, M., Zembala-John, J., & Adamek, B. (2022) · Vaccines · doi:10.3390/vaccines10091546 · Cited by 3 · see citing works

Impaired Cellular and Antibody immunity after COVID-19 in Chronically Immunosuppressed Transplant Recipients

Ashokkumar, C., Rohan, V., & Kroemer, A. (2023) · Journal of Surgery and Research · doi:10.26502/jsr.10020321 · Cited by 3 · see citing works

A novel chimeric coronavirus spike vaccine combining SARS-CoV-2 RBD and scaffold domains from HKU-1 elicits potent neutralising antibody responses

Zoest, V. P., Lee, W. S., Murdiyarso, L., Burmas, L., Pymm, P., Esterbauer, R., Kelly, A. P., Kelly, H. G., Barber-Axthelm, I. M., Cooney, J. P., et al. (2025) · npj Vaccines · doi:10.1038/s41541-025-01323-6 · Cited by 2 · see citing works

Preexisting vs. de novo antibodies against SARS-CoV-2 in individuals without or with virus infection: impact on antibody therapy, vaccine research and serological testing

Muthumani, K., Xu, Z., Jeong, M., Maslow, J. N., Kalyanaraman, V. S., & Srinivasan, A. (2021) · Translational Medicine Communications · doi:10.1186/s41231-021-00093-2 · Cited by 2 · see citing works

SARS-CoV-2 spike antigen-specific B cell and antibody responses in pre-vaccination period COVID-19 convalescent males and females with or without post-covid conditionPreprint

Limoges, M.-A., Quenum, A., Chowdhury, M. M. H., Rexhepi, F., Namvarpour, M., Akbari, S. A., Rioux‐Perreault, C., Nandi, M., Lucier, J., Lemaire‐Paquette, S., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.04.13.535896 · Cited by 2 · see citing works

Distinct T Cell Functional Profiles in Sars-Cov-2 Seropositive and Seronegative Children Associated with Endemic Human Coronavirus Cross-ReactivityPreprint

Benede, N., Tincho, M. B., Walters, A., Subbiah, V., Ngomti, A., Baguma, R., Butters, C., Hähnle, L., Mennen, M., Skelem, S., et al. (2023) · medRxiv · doi:10.1101/2023.05.16.23290059 · Cited by 2 · see citing works

Dengue amidst COVID-19: challenges & control measures for the double burden

Moi, M. L. (2021) · Uirusu · doi:10.2222/jsv.71.1 · Cited by 1 · see citing works

Low-dose fluoride exposure disrupts CD4+ T cell balance in humans and rats

Zhou, J., Zhu, S., Zhang, Y., Xie, F., Liu, B., Yuan, L., Liu, X., Sun, D., & Wei, W. (2025) · Environmental Research · doi:10.1016/j.envres.2025.122482 · Cited by 1 · see citing works

Human HKU1-Reactive CD4 T Cells Are Enriched for Cytolytic Potential That Persists in Older Adults

White, C. L., Richards, K. A., Huertas, N., Nayak, J. L., & Sant, A. J. (2025) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaf026 · Cited by 1 · see citing works

Could the candidate causal gene (LZTFL1) identified by Oxford University scientists, which doubles the risk of COVID-19-related respiratory failure, be used to boost the Weak immunogenicity of COVID-19 mRNA vaccines in patients with B-cell chronic lymphocytic leukemia (CLL)???. A double edged swardPreprint

Elkazzaz, M., Abo-Amer, Y. E.-E., Ahmed, A. K. K., & Haydara, T. (2021) · Research Square · doi:10.21203/rs.3.rs-1079599/v2 · Cited by 1 · see citing works

Long-term and short-term immunity to SARS-CoV-2: why it matters

Zaunders, J. J., & Phetsouphanh, C. (2021) · Microbiology Australia · doi:10.1071/ma21010

Could the candidate causal gene (LZTFL1) identified by Oxford University scientists, which doubles the risk of COVID-19-related respiratory failure, be used to improve and boost the Weak immunogenicity of COVID-19 mRNA vaccines in patients with hematologic malignancies???. A double edged swordPreprint

Elkazzaz, M., Abo-Amer, Y. E.-E., Ahmed, A. K. K., & Haydara, T. (2021) · Research Square · doi:10.21203/rs.3.rs-1079599/v1

Could the candidate causal gene (LZTFL1) identified by Oxford University scientists, which doubles the risk of COVID-19-related respiratory failure, be used to boost the Weak immunogenicity of COVID-19 mRNA vaccines in patients with B-cell chronic lymphocytic leukemia (CLL)???. A double edged swardPreprint

Elkazzaz, M., Abo-Amer, Y. E.-E., Ahmed, A. K. K., & Haydara, T. (2021) · Research Square · doi:10.21203/rs.3.rs-1079599/v3

Could the candidate causal gene (LZTFL1) identified by Oxford University scientists, which doubles the risk of COVID-19-related respiratory failure, be used to boost the Weak immunogenicity of COVID-19 mRNA vaccines in patients with B-cell chronic lymphocytic leukemia (CLL)???. A double edged swordPreprint

Elkazzaz, M., Abo-Amer, Y. E.-E., Haydara, T., Sarohan, A. R., & Ahmed, A. K. K. (2021) · Research Square · doi:10.21203/rs.3.rs-1079599/v4

Volume 42 Number 1

(2021) · Microbiology Australia · doi:10.1071/mav42n1

First and Second Generation Nucleoside Triphosphate Prodrugs: TriPPPro-Compounds for Antiviral Chemotherapy

Jia, X. D., Zhao, C., & Meier, C. (2022) · Springer eBooks · doi:10.1007/978-981-16-1313-5_72-1

Evidence for broad cross-reactivity of the SARS-CoV-2 NSP12-directed CD4+ T-cell response with pre-primed responses directed against common cold coronaviruses

Westphal, T., Mäder, M., Karsten, H., Cords, L., Knapp, M., Schulte, S., Hermanussen, L., Peine, S., Ditt, V., Grifoni, A., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1182504 · Cited by 9 · see citing works

The prospect of universal coronavirus immunity: a characterization of reciprocal and non-reciprocal T cell responses against SARS-CoV2 and common human coronavirusesPreprint

Soni, M. K., Migliori, E., Fu, J., Assal, A., Chan, H. T., Pan, J., Khatiwada, P., Ciubotariu, R., May, M. S., Pereira, M. R., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.03.519511 · Cited by 2 · see citing works

The prospect of universal coronavirus immunity: characterization of reciprocal and non-reciprocal T cell responses against SARS-CoV2 and common human coronaviruses

Soni, M., Migliori, E., Fu, J., Assal, A., Chan, H. T., Pan, J., Khatiwada, P., Ciubotariu, R., May, M. S., Pereira, M. R., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1212203 · Cited by 11 · see citing works

SARS-CoV-2-reactive T cells in patients and healthy donors

Pia, L. (2020) · Nature reviews. Immunology · doi:10.1038/s41577-020-0333-2 · Cited by 29 · see citing works

Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans

Mateus, J., Grifoni, A., Tarke, A., Sidney, J., Ramirez, S. I., Dan, J. M., Burger, Z. C., Rawlings, S. A., Smith, D. M., Phillips, E., et al. (2020) · Science · doi:10.1126/science.abd3871 · Cited by 1,120 · see citing works